Related Experiment Video
Updated: Feb 26, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
[Prevention of respiratory syncytial virus in children]
Sidse Vang Braa Andersen1, Lisbeth Samsø Schmidt2, Ulla Birgitte Hartling3
1Det Sundhedsvidenskabelige Fakultet, Københavns Universitet.
Insights
New RSV prevention strategies, including maternal vaccination and monoclonal antibodies, are set to significantly decrease infant hospitalizations in Denmark. These advancements offer improved protection against respiratory syncytial virus (RSV) for vulnerable infants.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Respiratory syncytial virus (RSV) is a primary cause of infant hospitalizations in Denmark, with approximately 1,300 annual admissions.
- Current prevention methods, such as palivizumab for high-risk infants, are limited by high costs and the need for monthly injections.
Purpose of the Study:
- To review emerging preventive strategies for RSV in infants.
- To highlight new options including maternal vaccination and monoclonal antibodies.
Main Methods:
- Review of current literature on RSV prevention.
- Description of novel prophylactic agents: maternal vaccination (Abrysvo) and monoclonal antibodies (nirsevimab, clesrovimab).
Main Results:
- Denmark's introduction of seasonal maternal vaccination (Abrysvo) from October 2025 is anticipated to significantly lower RSV hospitalizations.
- Monoclonal antibodies (nirsevimab, clesrovimab) are recommended for premature and high-risk infants.
Conclusions:
- New preventive measures promise a substantial reduction in RSV burden among infants.
- Maternal vaccination and monoclonal antibodies represent a significant advancement in pediatric infectious disease control.
Abstract:
Respiratory syncytial virus (RSV) is the leading cause of infant hospitalisations in Denmark, with about 1,300 admissions annually. Until now, prevention relied on palivizumab for high-risk infants, limited by high costs and monthly injections. This review describes new preventive options including maternal vaccination (Abrysvo) and monoclonal antibodies (nirsevimab, clesrovimab). From October 2025, Denmark introduced a seasonal maternal vaccination, expected to substantially reduce RSV-related hospitalisations. Additionally, monoclonal antibodies are recommended for premature and high-risk infants.
More Related Videos
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

